ArticlePharmacology research & perspectives2019

Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition.

Martin E Dowty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.